secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 75459 grounded facts newest July 16, 2026, 5:23 PM ET RSS · JSON

Showing 7501–7550 of 33113

Departed

David Natan

Member of the Board of Directors
NBND · NetBrands Corp.
Effective
2024-08-12
Filed
August 12, 2024, 7:59 PM ET
On August 12, 2024, David Natan delivered his resignation as a member of the Company’s Board of Directors, effective immediately.
Departed (interim)

Jeffrey Quick

interim Chief Executive Officer
SCWO · 374Water Inc.
Effective
2024-04-22
Successor
Christian Gannon
Filed
August 12, 2024, 7:59 PM ET
Jeffrey Quick will cease to be the interim Chief Executive Officer of the Company on that date.
Departed

Edwin Artuz

Chief Administrative Officer
Federal Home Loan Bank of New York
Effective
2024-07-01
Filed
August 12, 2024, 7:59 PM ET
Mr. Edwin Artuz, Chief Administrative Officer, Director of Diversity & Inclusion, and Senior Vice President of the Bank, would no longer be working at the Bank effective as of the close of business on July 1, 2024.
Departed

Phu Hoang

Director
LTRX · LANTRONIX INC
Effective
2024-08-09
Filed
August 12, 2024, 7:59 PM ET
Effective as of the date of the Agreement, Jason Cohenour and Phu Hoang have agreed not to stand for re-election at the 2024 Annual Meeting in order to ensure the Company’s compliance with the Agreement.
Departed

Jason Cohenour

Director
LTRX · LANTRONIX INC
Effective
2024-08-09
Filed
August 12, 2024, 7:59 PM ET
Effective as of the date of the Agreement, Jason Cohenour and Phu Hoang have agreed not to stand for re-election at the 2024 Annual Meeting in order to ensure the Company’s compliance with the Agreement.
Departed

Enrike Bokuchava

independent director
ANKM · Ankam, Inc.
Effective
2024-08-08
Filed
August 12, 2024, 7:59 PM ET
On August 8, 2024, Enrike Bokuchava submitted his resignation from independent director with the Company effective immediately.
Departed

Bakur Kalichava

President, Treasurer, Director and Secretary
ANKM · Ankam, Inc.
Effective
2024-08-08
Successor
Wang Wen Lung
Filed
August 12, 2024, 7:59 PM ET
As of August 8, 2024, Bakur Kalichava, the President, Treasurer, Director and Secretary of ANKAM INC. (the “Company”), is no longer holding the positions.
Departed

Peter Wilver

director
SHLS · Shoals Technologies Group, Inc.
Effective
2024-08-09
Successor
Niharika Taskar Ramdev
Filed
August 12, 2024, 7:59 PM ET
On August 7, 2024, Peter Wilver resigned from the board of directors (the “Board”) of Shoals Technologies Group, Inc. (the “Company”), effective as of August 9, 2024.
Departed

Paul W. Taylor

Director
HEARTLAND FINANCIAL USA INC
Effective
2024-08-07
Filed
August 9, 2024, 7:59 PM ET
On August 9, 2024, Heartland Financial USA, Inc. (the “Company”) announced that Paul W. Taylor resigned from the Company’s Board of Directors effective August 7, 2024.
Departed

Steen Karsbo

Director
META MATERIALS INC.
Effective
2024-08-09
Filed
August 9, 2024, 7:59 PM ET
each of John R. Harding, Allison Christilaw, Steen Karsbo, Kenneth Hannah, Vyomesh Joshi and Philippe Morali tendered their resignations as members of the Board of Directors.
Departed

Vyomesh Joshi

Director
META MATERIALS INC.
Effective
2024-08-09
Filed
August 9, 2024, 7:59 PM ET
each of John R. Harding, Allison Christilaw, Steen Karsbo, Kenneth Hannah, Vyomesh Joshi and Philippe Morali tendered their resignations as members of the Board of Directors.
Departed

Philippe Morali

Director
META MATERIALS INC.
Effective
2024-08-09
Filed
August 9, 2024, 7:59 PM ET
each of John R. Harding, Allison Christilaw, Steen Karsbo, Kenneth Hannah, Vyomesh Joshi and Philippe Morali tendered their resignations as members of the Board of Directors.
Departed

Dan Eaton

Chief Legal Officer
META MATERIALS INC.
Effective
2024-08-09
Filed
August 9, 2024, 7:59 PM ET
Company terminated all of its remaining employees and executive officers, including Uzi Sasson, its President and Chief Executive Officer, and Dan Eaton, its Chief Legal Officer
Departed

Uzi Sasson

President and Chief Executive Officer
META MATERIALS INC.
Effective
2024-08-09
Filed
August 9, 2024, 7:59 PM ET
Company terminated all of its remaining employees and executive officers, including Uzi Sasson, its President and Chief Executive Officer, and Dan Eaton, its Chief Legal Officer
Departed

John R. Harding

Director
META MATERIALS INC.
Effective
2024-08-09
Filed
August 9, 2024, 7:59 PM ET
each of John R. Harding, Allison Christilaw, Steen Karsbo, Kenneth Hannah, Vyomesh Joshi and Philippe Morali tendered their resignations as members of the Board of Directors.
Departed

Kenneth Hannah

Director
META MATERIALS INC.
Effective
2024-08-09
Filed
August 9, 2024, 7:59 PM ET
each of John R. Harding, Allison Christilaw, Steen Karsbo, Kenneth Hannah, Vyomesh Joshi and Philippe Morali tendered their resignations as members of the Board of Directors.
Departed

Allison Christilaw

Director
META MATERIALS INC.
Effective
2024-08-09
Filed
August 9, 2024, 7:59 PM ET
each of John R. Harding, Allison Christilaw, Steen Karsbo, Kenneth Hannah, Vyomesh Joshi and Philippe Morali tendered their resignations as members of the Board of Directors.
Departed

Peder K. Jensen

Director
Acorda Therapeutics, Inc.
Filed
August 9, 2024, 7:59 PM ET
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
Departed

Kerry Clem

Chief Commercial Officer
Acorda Therapeutics, Inc.
Filed
August 9, 2024, 7:59 PM ET
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
Departed

Thomas Burns

Director
Acorda Therapeutics, Inc.
Filed
August 9, 2024, 7:59 PM ET
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
Departed

Sandra Panem

Director
Acorda Therapeutics, Inc.
Filed
August 9, 2024, 7:59 PM ET
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
Departed

John P. Kelley

Director
Acorda Therapeutics, Inc.
Filed
August 9, 2024, 7:59 PM ET
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
Departed

Neil S. Belloff

General Counsel and Corporate Secretary
Acorda Therapeutics, Inc.
Filed
August 9, 2024, 7:59 PM ET
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
Departed

Ron Cohen

Chief Executive Officer
Acorda Therapeutics, Inc.
Filed
August 9, 2024, 7:59 PM ET
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
Departed

Michael A. Gesser

Chief Financial Officer and Treasurer
Acorda Therapeutics, Inc.
Filed
August 9, 2024, 7:59 PM ET
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
Departed

John Varian

Director
Acorda Therapeutics, Inc.
Filed
August 9, 2024, 7:59 PM ET
each of Ron Cohen, M.D., Chief Executive Officer and member of the Company’s Board of Directors (the “Board”), Thomas Burns, Peder K. Jensen, M.D., John P. Kelley, Sandra Panem, Ph.D., John Varian, members of the Board, and Michael A. Gesser, Chief Financial Officer and Treasurer, Neil S. Belloff, General Counsel and Corporate Secretary, and Kerry Clem, Chief Commercial Officer will each be deemed to have resigned from their respective positions as directors and officers of the Company.
Departed

Todd Magazine

Chief Executive Officer
AIRS · Airsculpt Technologies, Inc.
Effective
2024-08-08
Successor
Dennis Dean
Filed
August 9, 2024, 7:59 PM ET
On August 8, 2024, Todd Magazine stepped down from his role as Chief Executive Officer of AirSculpt Technologies, Inc. (the “Company”), effective as of August 8, 2024.
Departed

Todd Magazine

member of the board of directors
AIRS · Airsculpt Technologies, Inc.
Effective
2024-08-08
Filed
August 9, 2024, 7:59 PM ET
In connection with stepping down from his role as Chief Executive Officer of the Company, Mr. Magazine resigned from his position as a member of the board of directors of the Company (the “Board”), effective as of August 8, 2024.
Departed

Michele Logan

Director
GPGI · GPGI, Inc.
Effective
2024-08-07
Filed
August 9, 2024, 7:59 PM ET
on August 7, 2024, each of Mitchell Hollin and Michele Logan delivered notice of their resignation as a member of the Board and all committees thereof, subject to and contingent on the consummation of the Closing, pursuant to the terms of the Letter Agreement.
Departed

Mitchell Hollin

Director
GPGI · GPGI, Inc.
Effective
2024-08-07
Filed
August 9, 2024, 7:59 PM ET
on August 7, 2024, each of Mitchell Hollin and Michele Logan delivered notice of their resignation as a member of the Board and all committees thereof, subject to and contingent on the consummation of the Closing, pursuant to the terms of the Letter Agreement.
Departed

James Fairweather

Executive Vice President and Chief Innovation Officer
PBI · PITNEY BOWES INC /DE/
Effective
2025-04-01
Filed
August 9, 2024, 7:59 PM ET
The employment of James Fairweather as Executive Vice President and Chief Innovation Officer at the Company will end, effective April 1, 2025
Departed

Craig Hibbard

Chief Development Officer
BGDE · Big Digital Energy, Inc.
Effective
2025-02-06
Filed
August 9, 2024, 7:59 PM ET
Mawson Infrastructure Group Inc. (the “Company”) announces the departure of Mr. Craig Hibbard as the Company’s Chief Development Officer given personal reasons.
Departed

Michael C. Morgan

Class I Director
Sunnova Energy International Inc.
Effective
2024-10-07
Filed
August 9, 2024, 7:59 PM ET
On August 8, 2024, Michael C. Morgan notified the Company of his resignation as a Class I director of the Board of Directors of the Company and member of the Compensation and Human Capital Committee effective October 7, 2024.
Departed

Shanchun Huang

Chief Executive Officer and President
FTFT · Future FinTech Group Inc.
Effective
2024-08-05
Successor
Hu Li
Filed
August 9, 2024, 7:59 PM ET
On August 5, 2024, the Board of Directors (the “Board”) of Future FinTech Group, Inc. (the “Company”) received a resignation letter from Mr. Shanchun Huang to resign from his positions as a director of the Board and the Chief Executive Officer (“CEO”) and President of the Company, effective on August 5, 2024.
Departed

Lawrence K. Lin

Executive Vice President of Operations
AIMD · Ainos, Inc.
Effective
2024-08-09
Filed
August 9, 2024, 7:59 PM ET
As of August 9, 2024, Lawrence K. Lin transitioned from his role as the Company’s Executive Vice President of Operations, effective August 9, 2024.
Departed

Amir Avniel

Director
XAIR · Beyond Air, Inc.
Effective
2024-08-15
Filed
August 9, 2024, 7:59 PM ET
tendered his resignation from the board of directors of the Company and as the Chief Business Officer of the Company.
Departed

Amir Avniel

Chief Business Officer
XAIR · Beyond Air, Inc.
Effective
2024-08-15
Filed
August 9, 2024, 7:59 PM ET
tendered his resignation from the board of directors of the Company and as the Chief Business Officer of the Company.
Departed

Sabrina Ellis

Chief Product Officer
PINS · PINTEREST, INC.
Effective
2024-09-21
Filed
August 9, 2024, 7:59 PM ET
On August 9, 2024, Pinterest, Inc. (the “Company”) announced that Sabrina Ellis, the Company’s Chief Product Officer would, effective immediately, transition to an advisory role and then transition from the Company to pursue other career opportunities, effective as of September 21, 2024.
Departed

Irina Pestrikova

Senior Director, Finance
NDRA · ENDRA Life Sciences Inc.
Effective
2024-08-07
Successor
Richard Jacroux
Filed
August 9, 2024, 7:59 PM ET
On August 5, 2024, Irina Pestrikova notified ENDRA Life Sciences Inc. (“ENDRA” or the “Company”) of her resignation as the Company’s Senior Director, Finance, effective August 7, 2024.
Departed

Michael C. Morgan

Director
STEM · STEM, INC.
Effective
2024-10-07
Filed
August 9, 2024, 7:59 PM ET
On August 8, 2024, Michael C. Morgan notified the Board of Directors (the “Board”) and the Corporate Secretary of Stem, Inc. (the “Company”) of his resignation from the Board effective October 7, 2024 for personal reasons.
Departed

Jeremy Bezdek

Executive Vice President Corporate Development
TE · T1 Energy Inc.
Effective
2024-08-08
Filed
August 9, 2024, 7:59 PM ET
On August 5, the Company notified Jeremy Bezdek, EVP Corporate Development, that his employment with the Company would terminate, effective August 8, 2024
Departed

Anthony Clark

Director
NWE · NorthWestern Energy Group, Inc.
Effective
2024-12-31
Filed
August 9, 2024, 7:59 PM ET
On August 7, 2024, Anthony Clark notified NorthWestern Energy Group, Inc. d/b/a NorthWestern Energy (Nasdaq: NWE) (the “ Company ”) of his intent to resign as a member of the Company's Board of Directors (the “ Board ”) effective December 31, 2024.
Departed

Curtis J. Dobler

Executive Vice President and Chief Human Resources Officer
APOG · APOGEE ENTERPRISES, INC.
Effective
2024-08-08
Successor
Raelyn A. Trende
Filed
August 8, 2024, 7:59 PM ET
Curtis J. Dobler resigned as the Company’s Executive Vice President and Chief Human Resources Officer.
Departed

David L. Gamsey

Executive Vice President and Chief Financial Officer
FA · FIRST ADVANTAGE CORP
Effective
2024-11-08
Successor
Steven Marks
Filed
August 8, 2024, 7:59 PM ET
On August 5, 2024, David L. Gamsey notified the Company of his intent to retire from his position as Executive Vice President and Chief Financial Officer, effective November 8, 2024.
Departed

Ronald B. Kalich

Director
SURMODICS INC
Effective
2024-08-04
Filed
August 8, 2024, 7:59 PM ET
On August 4, 2024, Ronald B. Kalich resigned from the Board of Directors of Surmodics, Inc. (the “Company”). Mr. Kalich stated that he was resigning for health reasons.
Departed

Marc Wilson

Chief Financial Officer
CRNX · Crinetics Pharmaceuticals, Inc.
Filed
August 8, 2024, 7:59 PM ET
On August 5, 2024, Marc Wilson notified the Company of his decision to step down from his position as Chief Financial Officer of the Company.
Departed

Leone Patterson

Chief Financial and Business Officer
TNYA · Tenaya Therapeutics, Inc.
Effective
2024-08-14
Filed
August 8, 2024, 7:59 PM ET
Effective August 14, 2024, upon Ms. Leone Patterson ceasing to be the Chief Financial and Business Officer, Principal Financial Officer (PFO) and Principal Accounting Officer (PAO) for Tenaya
Departed

Terry J. Schadeberg

President, Americas
CMCO · COLUMBUS MCKINNON CORP
Effective
2024-09-20
Successor
Jon Adams
Filed
August 8, 2024, 7:59 PM ET
On August 6, 2024, Terry J. Schadeberg, President, Americas, of Columbus McKinnon Corporation (the “Company”) notified the Company that he plans to retire from the Company effective September 20, 2024.
Departed

Kathleen Cunningham

Director
RMAX · RE/MAX Holdings, Inc.
Effective
2024-08-19
Successor
Cathleen Raffaeli
Filed
August 8, 2024, 7:59 PM ET
Kathleen Cunningham informed the Company that she would retire from the Company’s Board of Directors (the “Board”), effective August 19, 2024.
Departed

Alex van Hoek

Director
HGV · Hilton Grand Vacations Inc.
Effective
2024-08-07
Successor
Christine Cahill
Filed
August 8, 2024, 7:59 PM ET
Effective as of August 7, 2024, Mr. van Hoek resigned from the Board.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.